JamesMichaelFinkMD

Pathology • Minneapolis, MN

Anatomic Pathology, Clinical Pathology

Assistant Professor, Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis

Join to view full profile

Dr. Fink is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fink's full profile

Already have an account?

Office
701 Park Ave
Clinical Laboratories P4
Minneapolis, MN 55415
Phone+1 612-873-8525

Fax+1 612-904-4230

Education & Training

University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1992 - 1996
University of Minnesota Medical SchoolClass of 1991

Certifications & Licensure

MN State Medical License 1996 - 2025
American Board of Pathology Clinical Pathology
American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics

Publications & Presentations

PubMed

1 citations
Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphom...
Ashwini K Yenamandra, Rebecca B Smith, T Niroshi Senaratne, Sung-Hae L Kang, James M Fink
Cancer Genetics. 2022-11-01
10 citations
Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations.
Jess F. Peterson, Ross A. Rowsey, Cherisse A. Marcou, Kathryn E. Pearce, Cynthia M. Williamson
Blood Cancer Journal. 2019-02-19
13 citations
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium wo...
Trevor J. Pugh, James M. Fink, Xinyan Lu, Susan Mathew, Joyce Murata-Collins
Cancer Genetics. 2018-10-05